Heron Therapeutics is trading 5.26% up at $0.33 on October 1, 2026; the reason for the gain remains unclear. - Its latest listed news release is its August 10, 2026 second-quarter results; the release archive shows no October 1 announcement. - The supplied broader market indicators are mixed, each moving less than 0.5%, and do not clearly explain the gain.